Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study

Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute cor...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 19; no. 1; p. 5
Main Authors Yang, Ye Seul, Yang, Bo Ram, Kim, Mi-Sook, Hwang, Yunji, Choi, Sung Hee
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.01.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
AbstractList Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients ( n  = 224,837) and newly defined high-risk patients ( n  = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
BACKGROUNDReal-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS).METHODSThis was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD).RESULTSOverall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015).CONCLUSIONSLDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Keywords: Dyslipidaemia, Low density lipoprotein cholesterol, Stroke, Acute coronary syndrome, Cardiovascular disease, Diabetes mellitus, Statin
Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice.
ArticleNumber 5
Audience Academic
Author Yang, Bo Ram
Kim, Mi-Sook
Choi, Sung Hee
Yang, Ye Seul
Hwang, Yunji
Author_xml – sequence: 1
  givenname: Ye Seul
  surname: Yang
  fullname: Yang, Ye Seul
  organization: Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea
– sequence: 2
  givenname: Bo Ram
  surname: Yang
  fullname: Yang, Bo Ram
  organization: Medical Research Collaborating Center, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea
– sequence: 3
  givenname: Mi-Sook
  surname: Kim
  fullname: Kim, Mi-Sook
  organization: Department of Preventive Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea
– sequence: 4
  givenname: Yunji
  surname: Hwang
  fullname: Hwang, Yunji
  organization: Amgen Korea, 19 Eulji-ro 5-gil, Jung-gu, Seoul, Republic of Korea
– sequence: 5
  givenname: Sung Hee
  orcidid: 0000-0003-0740-8116
  surname: Choi
  fullname: Choi, Sung Hee
  email: shchoimd@gmail.com, shchoimd@gmail.com
  organization: Department of Internal Medicine, Division of Endocrinology & Metabolism, Seoul National University Bundang Hospital, 82, Gumi-ro 173Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. shchoimd@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31926562$$D View this record in MEDLINE/PubMed
BookMark eNptks1u1DAUhSNURNuBB2CDLLHpJsWOf5KwQKoqfipGYgMSO-vGvpnxkIkH25lqHom3xNMppYNQFknsc74rH5_z4mT0IxbFS0YvGWvUm8iqVoiSsrZkTDalfFKcMVGrUjL2_eTR92lxHuOK0orWSj0rTjlrKyVVdVb8mvvb0uIYXdqRwW38JviEbiRm6QeMCYMfyMLDQCAlcOMax0QCJIwki5ZusSyDiz_IBpLLW5HcurQkBoJ1fgvRTAMEYl1EiNkCo80_0OHev8ZhcGm6A332AeEtARIwBR83aJLbIjF-6UMiMU1297x42sMQ8cX9e1Z8-_D-6_Wncv7l48311bw0UtFUGqwYglTc2LZr-srUnbFS9EJBW3fYKMlZB73gKKiBWlnkTdv2AvumV401fFbcHLjWw0pvgltD2GkPTt8t-LDQEJIzA-oWbQON7SWXGchqkBlRdW1lBac8T5oV7w6szdSt0ZqcUIDhCHq8M7qlXvitVq0UUrYZcHEPCP7nlO9Dr100OTgY0U9RV5zXtK4oo1n6-h_pyk9hzFFllWBcCtayv6oF5AO4sfd5rtlD9ZViTc1qQfdjL_-jyo_FtTO5hL3L60cGdjCYfHsxYP9wRkb1vqv60FWdu6r3XdX7cF49DufB8aec_DdU_usD
CitedBy_id crossref_primary_10_12997_jla_2023_12_2_175
crossref_primary_10_1097_MCA_0000000000001138
crossref_primary_10_1016_j_ijcard_2021_12_020
crossref_primary_10_1016_j_cpcardiol_2021_101068
crossref_primary_10_4093_dmj_2022_0448
crossref_primary_10_4235_agmr_21_0099
crossref_primary_10_1016_j_dsx_2023_102784
crossref_primary_10_1016_j_ajpc_2020_100040
crossref_primary_10_1186_s12944_021_01455_3
crossref_primary_10_1016_j_ijcard_2020_06_059
crossref_primary_10_4093_dmj_2021_0088
crossref_primary_10_1089_met_2023_0310
crossref_primary_10_4103_hm_hm_3_20
crossref_primary_10_1016_j_jacl_2023_04_002
crossref_primary_10_1186_s12933_022_01495_8
crossref_primary_10_1186_s12933_021_01338_y
crossref_primary_10_1371_journal_pone_0296298
crossref_primary_10_12997_jla_2023_12_1_12
crossref_primary_10_12997_jla_2023_12_3_277
crossref_primary_10_1016_j_amjcard_2023_11_067
Cites_doi 10.1016/j.clpt.2005.06.013
10.1016/j.atherosclerosis.2016.07.001
10.4093/dmj.2011.35.6.628
10.1161/01.cir.0000437738.63853.7a
10.1016/j.amjcard.2006.08.051
10.1111/j.1368-5031.2005.00646.x
10.1093/eurheartj/ehw272
10.1177/000331970505600611
10.1016/j.clinthera.2017.03.001
10.4158/EP171764.APPGL
10.1371/journal.pone.0191817
10.1016/j.ijcard.2018.04.068
10.1186/s12944-018-0945-8
10.1016/S0140-6736(10)61350-5
10.1371/journal.pone.0146272
10.1056/NEJM199811053391902
10.24304/kjcp.2017.27.4.276
10.1136/bmjopen-2017-016640
10.4093/dmj.2013.37.6.433
10.5551/jat.15792
10.1016/j.cjca.2016.07.510
10.3803/EnM.2017.32.1.30
10.1056/NEJM199610033351401
10.1016/j.ijcard.2018.01.099
10.4093/dmj.2017.41.1.20
10.1016/j.atherosclerosis.2017.11.020
10.7326/AITC201712050
10.1161/CIRCRESAHA.117.308903
10.1016/j.jacc.2016.03.519
10.1016/j.cjca.2016.10.019
10.1016/j.jacc.2018.11.002
10.3349/ymj.2017.58.2.326
10.1001/jama.285.19.2486
10.5551/jat.RV16004
10.1016/S0140-6736(16)31012-1
10.1056/NEJMoa050461
10.4070/kcj.2016.46.3.275
10.1080/03007995.2017.1292898
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PIMPY
PQEST
PQQKQ
PQUKI
RC3
7X8
5PM
DOA
DOI 10.1186/s12944-019-1158-5
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic


Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Statistics
EISSN 1476-511X
EndPage 5
ExternalDocumentID oai_doaj_org_article_9ed8a8df535f4317a5f682b92d430365
A618717409
10_1186_s12944_019_1158_5
31926562
Genre Journal Article
GeographicLocations Republic of Korea
South Korea
GeographicLocations_xml – name: Republic of Korea
– name: South Korea
GrantInformation_xml – fundername: ;
GroupedDBID ---
-A0
0R~
29L
2WC
3V.
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFGXO
AFKRA
AFNRJ
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
E3Z
EAD
EAP
EAS
EBD
EBS
ECM
EIF
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
P6G
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAHBH
AAYXX
ALIPV
CITATION
EBLON
PGMZT
ABVAZ
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
K9.
P64
PQEST
PQUKI
RC3
7X8
5PM
ID FETCH-LOGICAL-c560t-ce21ea563cd9b8f2c7bcd54f46a97be86531baf43e40ca76de3899f4ef8f68dc3
IEDL.DBID RPM
ISSN 1476-511X
IngestDate Thu Jul 04 21:11:28 EDT 2024
Tue Sep 17 21:25:48 EDT 2024
Sat Aug 17 05:43:56 EDT 2024
Fri Sep 13 01:26:37 EDT 2024
Fri Feb 23 00:12:48 EST 2024
Fri Feb 02 04:14:01 EST 2024
Thu Sep 12 16:21:13 EDT 2024
Thu May 23 23:26:12 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Stroke
Diabetes mellitus
Low density lipoprotein cholesterol
Cardiovascular disease
Dyslipidaemia
Statin
Acute coronary syndrome
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-ce21ea563cd9b8f2c7bcd54f46a97be86531baf43e40ca76de3899f4ef8f68dc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0740-8116
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954559/
PMID 31926562
PQID 2341354191
PQPubID 42587
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_9ed8a8df535f4317a5f682b92d430365
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6954559
proquest_miscellaneous_2337072010
proquest_journals_2341354191
gale_infotracmisc_A618717409
gale_infotracacademiconefile_A618717409
crossref_primary_10_1186_s12944_019_1158_5
pubmed_primary_31926562
PublicationCentury 2000
PublicationDate 2020-01-11
PublicationDateYYYYMMDD 2020-01-11
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-11
  day: 11
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Lipids in health and disease
PublicationTitleAlternate Lipids Health Dis
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JK Liao (1158_CR31) 2007; 99
Haidong Wang (1158_CR6) 2016; 388
L Kopin (1158_CR5) 2017; 167
SC Seong (1158_CR25) 2017; 46
E Lee (1158_CR30) 2005; 78
P Joseph (1158_CR7) 2017; 121
T Teramoto (1158_CR44) 2016; 251
1158_CR13
SK Kim (1158_CR32) 2017; 41
Long-Term Intervention with Pravastatin in Ischaemic Disease Study Group (1158_CR19) 1998; 339
JS Jeong (1158_CR11) 2017; 32
SC Seong (1158_CR24) 2017; 7
RS Punekar (1158_CR27) 2017; 33
R Naito (1158_CR29) 2017; 24
JG Kuiper (1158_CR38) 2017; 39
YH Lee (1158_CR10) 2014; 3
FD Hobbs (1158_CR37) 2005; 59
BP Yan (1158_CR39) 2018; 265
H Wouters (1158_CR33) 2016; 11
PS Jellinger (1158_CR4) 2017; 23
Y Choi (1158_CR16) 2017; 27
AL Catapano (1158_CR15) 2016; 37
JY Hwang (1158_CR35) 2011; 35
C Baigent (1158_CR21) 2010; 376
1158_CR26
1158_CR23
J Lee (1158_CR12) 2017; 58
Q Hou (1158_CR42) 2019; 18
DM Lloyd-Jones (1158_CR28) 2016; 68
1158_CR8
C Breuker (1158_CR41) 2018; 268
T Teramoto (1158_CR43) 2013; 20
W März (1158_CR40) 2018; 268
EJ Diamantopoulos (1158_CR36) 2005; 56
V Fung (1158_CR34) 2018; 13
1158_CR3
FM Sacks (1158_CR18) 1996; 335
E Roh (1158_CR9) 2013; 37
DD Waters (1158_CR17) 2017; 33
1158_CR2
TJ Anderson (1158_CR14) 2016; 32
1158_CR1
JC LaRosa (1158_CR20) 2005; 352
Scott M. Grundy (1158_CR22) 2019; 73
References_xml – volume: 78
  start-page: 330
  issue: 4
  year: 2005
  ident: 1158_CR30
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2005.06.013
  contributor:
    fullname: E Lee
– volume: 251
  start-page: 248
  year: 2016
  ident: 1158_CR44
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2016.07.001
  contributor:
    fullname: T Teramoto
– volume: 35
  start-page: 628
  issue: 6
  year: 2011
  ident: 1158_CR35
  publication-title: Diab Metab J
  doi: 10.4093/dmj.2011.35.6.628
  contributor:
    fullname: JY Hwang
– ident: 1158_CR3
  doi: 10.1161/01.cir.0000437738.63853.7a
– volume: 99
  start-page: 410
  issue: 3
  year: 2007
  ident: 1158_CR31
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.08.051
  contributor:
    fullname: JK Liao
– ident: 1158_CR23
– volume: 59
  start-page: 1171
  issue: 10
  year: 2005
  ident: 1158_CR37
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1368-5031.2005.00646.x
  contributor:
    fullname: FD Hobbs
– volume: 37
  start-page: 2999
  issue: 39
  year: 2016
  ident: 1158_CR15
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw272
  contributor:
    fullname: AL Catapano
– volume: 56
  start-page: 731
  issue: 6
  year: 2005
  ident: 1158_CR36
  publication-title: Angiol
  doi: 10.1177/000331970505600611
  contributor:
    fullname: EJ Diamantopoulos
– volume: 39
  start-page: 819
  issue: 4
  year: 2017
  ident: 1158_CR38
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2017.03.001
  contributor:
    fullname: JG Kuiper
– ident: 1158_CR8
– volume: 23
  start-page: 1
  issue: Suppl 2
  year: 2017
  ident: 1158_CR4
  publication-title: Endocr Pract
  doi: 10.4158/EP171764.APPGL
  contributor:
    fullname: PS Jellinger
– volume: 13
  start-page: e0191817
  issue: 2
  year: 2018
  ident: 1158_CR34
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0191817
  contributor:
    fullname: V Fung
– volume: 268
  start-page: 195
  year: 2018
  ident: 1158_CR41
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2018.04.068
  contributor:
    fullname: C Breuker
– volume: 18
  start-page: 13
  issue: 1
  year: 2019
  ident: 1158_CR42
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-018-0945-8
  contributor:
    fullname: Q Hou
– volume: 376
  start-page: 1670
  year: 2010
  ident: 1158_CR21
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61350-5
  contributor:
    fullname: C Baigent
– volume: 11
  start-page: e0146272
  issue: 1
  year: 2016
  ident: 1158_CR33
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0146272
  contributor:
    fullname: H Wouters
– volume: 339
  start-page: 1349
  issue: 19
  year: 1998
  ident: 1158_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199811053391902
  contributor:
    fullname: Long-Term Intervention with Pravastatin in Ischaemic Disease Study Group
– volume: 27
  start-page: 276
  issue: 4
  year: 2017
  ident: 1158_CR16
  publication-title: Korean J Clin Pharm
  doi: 10.24304/kjcp.2017.27.4.276
  contributor:
    fullname: Y Choi
– volume: 7
  issue: 9
  year: 2017
  ident: 1158_CR24
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2017-016640
  contributor:
    fullname: SC Seong
– volume: 37
  start-page: 433
  issue: 6
  year: 2013
  ident: 1158_CR9
  publication-title: Diabetes Metab J
  doi: 10.4093/dmj.2013.37.6.433
  contributor:
    fullname: E Roh
– volume: 20
  start-page: 517
  issue: 6
  year: 2013
  ident: 1158_CR43
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.15792
  contributor:
    fullname: T Teramoto
– volume: 32
  start-page: 1263
  issue: 11
  year: 2016
  ident: 1158_CR14
  publication-title: Can J Cardiol.
  doi: 10.1016/j.cjca.2016.07.510
  contributor:
    fullname: TJ Anderson
– volume: 32
  start-page: 30
  issue: 1
  year: 2017
  ident: 1158_CR11
  publication-title: Endocrinol Metab (Seoul)
  doi: 10.3803/EnM.2017.32.1.30
  contributor:
    fullname: JS Jeong
– volume: 335
  start-page: 1001
  issue: 14
  year: 1996
  ident: 1158_CR18
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199610033351401
  contributor:
    fullname: FM Sacks
– volume: 265
  start-page: 1
  year: 2018
  ident: 1158_CR39
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2018.01.099
  contributor:
    fullname: BP Yan
– volume: 41
  start-page: 20
  issue: 1
  year: 2017
  ident: 1158_CR32
  publication-title: Diab Metab J
  doi: 10.4093/dmj.2017.41.1.20
  contributor:
    fullname: SK Kim
– volume: 268
  start-page: 99
  year: 2018
  ident: 1158_CR40
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2017.11.020
  contributor:
    fullname: W März
– ident: 1158_CR1
– volume: 167
  start-page: ITC81
  year: 2017
  ident: 1158_CR5
  publication-title: Ann Intern Med
  doi: 10.7326/AITC201712050
  contributor:
    fullname: L Kopin
– volume: 121
  start-page: 677
  issue: 6
  year: 2017
  ident: 1158_CR7
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.117.308903
  contributor:
    fullname: P Joseph
– volume: 68
  start-page: 92
  issue: 1
  year: 2016
  ident: 1158_CR28
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.03.519
  contributor:
    fullname: DM Lloyd-Jones
– volume: 33
  start-page: 343
  issue: 3
  year: 2017
  ident: 1158_CR17
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2016.10.019
  contributor:
    fullname: DD Waters
– ident: 1158_CR26
– volume: 46
  start-page: 799
  issue: 3
  year: 2017
  ident: 1158_CR25
  publication-title: Int J Epidemiol
  contributor:
    fullname: SC Seong
– volume: 73
  start-page: 3168
  issue: 24
  year: 2019
  ident: 1158_CR22
  publication-title: Journal of the American College of Cardiology
  doi: 10.1016/j.jacc.2018.11.002
  contributor:
    fullname: Scott M. Grundy
– volume: 3
  issue: 1
  year: 2014
  ident: 1158_CR10
  publication-title: J Am Heart Assoc
  contributor:
    fullname: YH Lee
– volume: 58
  start-page: 326
  issue: 2
  year: 2017
  ident: 1158_CR12
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2017.58.2.326
  contributor:
    fullname: J Lee
– ident: 1158_CR2
  doi: 10.1001/jama.285.19.2486
– volume: 24
  start-page: 19
  issue: 1
  year: 2017
  ident: 1158_CR29
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.RV16004
  contributor:
    fullname: R Naito
– volume: 388
  start-page: 1459
  issue: 10053
  year: 2016
  ident: 1158_CR6
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(16)31012-1
  contributor:
    fullname: Haidong Wang
– volume: 352
  start-page: 1425
  year: 2005
  ident: 1158_CR20
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa050461
  contributor:
    fullname: JC LaRosa
– ident: 1158_CR13
  doi: 10.4070/kcj.2016.46.3.275
– volume: 33
  start-page: 869
  issue: 5
  year: 2017
  ident: 1158_CR27
  publication-title: Curr Med Res Opin
  doi: 10.1080/03007995.2017.1292898
  contributor:
    fullname: RS Punekar
SSID ssj0020766
Score 2.372327
Snippet Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to...
Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of...
Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this...
BACKGROUNDReal-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study...
Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 5
SubjectTerms Acute coronary syndrome
Acute Coronary Syndrome - blood
Acute Coronary Syndrome - pathology
Acute coronary syndromes
Aged
Antilipemic agents
Arteriosclerosis
Atherosclerosis
Atherosclerosis - blood
Atherosclerosis - pathology
Cardiac patients
Cardiology
Cardiovascular agents
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - blood
Cardiovascular Diseases - pathology
Care and treatment
Carotid arteries
Cholesterol
Cholesterol tests
Cholesterol, LDL - blood
Codes
Cohort analysis
Coronary artery disease
Coronary Disease - blood
Coronary Disease - pathology
Coronary heart disease
Diabetes
Diabetes mellitus
Diabetes Mellitus - blood
Diabetes Mellitus - pathology
Diseases
Dyslipidaemia
Dyslipidemia
Dyslipidemias
Female
Health
Health aspects
Health screening
Heart diseases
Humans
LDL cholesterol
Lipoproteins
Low density lipoprotein
Low density lipoprotein cholesterol
Low density lipoproteins
Male
Medical screening
Metabolic disorders
Middle Aged
National health insurance
Patients
Peripheral Arterial Disease - blood
Peripheral Arterial Disease - pathology
Republic of Korea - epidemiology
Retrospective Studies
Risk Factors
Risk groups
Society
Statins
Statistics
Stroke
Stroke - blood
Stroke - pathology
Stroke patients
Vascular diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9VAFB6kC3Ej2vqIVhlBFITQm2Se7q5iKWpdWehumKdeaJNyby7Sn-S_9JxJcrnBhRu3mZOQ5LxnvvmGkNdI6MJFbMrkcUuOrFhpZWRl0slrlpRdRGwUz7-Jswv2-ZJf7h31hZiwgR54-HEnOgZlVUi84QmTneVJqNrpOjCMvgN7acWnZmpstaA7F-MaZqXEyQayGkO0hS5BVpV8loUyWf_fIXkvJ83xknsJ6PQBuT9WjnQ5vPFDcie2h-Ro2ULXfH1L39CM5cyT5Ifk7vm4ZH5Efn_tfpUBYer9Lb1a3XSZmWHVUox7mSahu6I_Oniy7SdwAEX-iA0FIWQzLhF-TkcC1g3FmVvqZzBWOi7zbKhtA52mc-k1kn322_ygLx1Up--ppevYr7tpfyfF83nXPc0kt4_Ixemn7x_PyvF8htJDndSXPtZVtFw0PminUu2l84GzxITV0kUlwL-dBa1FtvBWihCRzC-xmBToMPjmMTlouzY-JTT5ELiUTjauYTxIx2xlmYUOOjgdAivIu0lf5mag4TC5fVHCDMo1oFyDyjW8IB9QoztBZNDOF8CuzGhX5l92VZC3aA8G_RyU7u24XQHeFxmzzFJU0GtKaI8LcjyTBP_08-HJoswYHzamxuKBM2iWC_JqN4x3Iuatjd0WZRq5kIhWKMiTwQB3nwSBswYfqwsiZ6Y5--b5SLv6mdnDhYaimetn_-MnPSf3apx_WFTgV8fkoF9v4wso0nr3MvvjHxu4PmY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA61BfFFtPUyWiWCKAhhd2ZymfFFttKyqC0iFvoWMrnUhXZmnZ1F-pP8l54zm1k7CL5usiHDueRcvnwh5DUSugjpcxYsXslRKWdGec5CGWzJQ2GmHhPF0zM5P-efLsTFDpkPd2EQVjn4xN5Ru8ZijXySobsVHNKLiamwCmC7yYflT4bvR2GfNT6mcYfsZSnHhu3e0fHZ12_b5AvydRm7mmkhJys45zjiL0oGMVHBxOhc6un7_3XSt06pMYLy1pF08oDcj7EknW2E_5Ds-HqfHMxqyKOvb-gb2qM7-7L5Prl7GpvoB-T3l-YXcwhc727o1WLZ9FwNi5qiJ-yJE5oretnAyqYb4AIUGSVWFCYhvzFDQDqNlKwrirVcakfAVhobPytqakeHAi-9RvrPbt0v9LmBePU9NbT1XdsMNz4pvtjbdrSnvX1Ezk-Ov3-cs_hiA7MQOXXM-iz1RsjcurIqQmZVZZ3ggUtTqsoXEiy-MoHnnk-tUdJ5pPcL3IciyMLZ_DHZrZvaPyU0WOeEUpXKq5wLpypuUsMN5NSuKp3jCXk3yEsvN8Qcuk9oCqk3wtUgXI3C1SIhRyjR7UTk1O5_aNpLHU1Ul94VpnBB5CJgWGUE7CmrysxxPOdhkbeoDxotH_XPxAsMsF_k0NIzmUL2qSBhTsjhaCZYrB0PDxqlo8dY6b_6nZBX22H8J6Lgat-scU6upgrxCwl5slHA7SeBK83A6rKEqJFqjr55PFIvfvR84rKEMFqUz_6_refkXoa1hmkKFnNIdrt27V9AQNZVL6Ot_QHprDt8
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA7rCrIvorNeqqtEEAWhOtPm0goio7gs6vjkwLyFNJd1YLZd2w46P8l_6TlpO2xxH3ydpJmm55zkO8mXL4Q8R0EXLlwae4NHcuSMxVo6Fvvcm5z5TE8dJoqLb-JsyT6v-OqADNdb9R-wuTa1w_uklvXm9e-fu_cQ8O9CwGfiTQNzFkMuRR4DvslifoPcTFjK0OEXbL-pkEDK3h02kiIGnLHqNzmvbWI0TQU1_3_H7CuT1phQeWWGOr1DbvfQks47X7hLDlw5IcfzEtLqix19QQPZM6yiT8itRb-nPiFHiDc7ueZj8udr9Su2SGpvd3SzvqyCjsO6pPihgqhCtaHnFfyNbgcqAUW1iYZCJdQ-jpGsTnu51obiOi81I9Ir7TeFGqpLS4fFX3qB0qDtNjT0pQIs-5ZqWru2robToBRv861bGiRx75Hl6afvH8_i_jaH2ACqamPjkpnTXKTG5kXmEyMLYznzTOhcFi4TMBoU2rPUsanRUliH0n-eOZ95kVmT3ieHZVW6h4R6Yy2XspBpkTJuZcH0TDMN-bYtcmtZRF4NxlOXnWiHCslOJlRnaQWWVmhpxSPyAc27r4h62-GHqj5Xffiq3NlMZ9bzlHuEXJrDOyVFnliGGAAaeYnOodBPwQOM7g83wPuivpaaixlkphKS6YicjGpCNJtx8eBeaggGlSDU4AxS64g82xfjk8iQK121xTqpnErkNkTkQeeN-y7BMJtARCYRkSM_HfV5XFKufwStcZEDxOb5o__u32NylOCSxHQGkXRCDtt6654AbmuLpyEa_wKgvUPe
  priority: 102
  providerName: Scholars Portal
Title Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
URI https://www.ncbi.nlm.nih.gov/pubmed/31926562
https://www.proquest.com/docview/2341354191/abstract/
https://search.proquest.com/docview/2337072010
https://pubmed.ncbi.nlm.nih.gov/PMC6954559
https://doaj.org/article/9ed8a8df535f4317a5f682b92d430365
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtB2MvY2t38doFDcYGAzexrYu9t7S0lG0pZayQNyHr0gUSOyQOpT9p_3LnKHao2dte_GDJQuaco3PRp0-EfERCFy5cFnuDR3JkwmItHYt94U3BfK5HDhPFybW4umXfpny6R3h3FiaA9k05O63mi9Nq9jtgK5cLM-xwYsObybkowO_zYrhP9mWWdSl6m2VBYi7a7cskF8M1ODSGQIsihuAnj_GqGlC7FGaY9nxRoOz_d2F-5Jn6qMlHbujyBXnexo90vJ3nS7LnqkNyNK4gd1480E80IDpDqfyQPJ20G-dH5M-P-j62CFZvHuh8tqwDP8Osorj6BbKEek7vahhZNx1EgCKLxJpCJ-Q0jhGETlsa1jXF-i01PTArbTd71lRXlnZFXbpAys9mEwb6XkOM-pVqunLNqu5OeVK8pXfV0EB1-4rcXl78Or-K21saYgPRUhMblyZOc5EZW5S5T40sjeXMM6ELWbpcgJWX2rPMsZHRUliHlH6eOZ97kVuTvSYHVV25t4R6Yy2XspRZmTFuZcl0opmGPNqWhbUsIl86eanlloxDhSQmF2orZwVyVihnxSNyhhLddUQe7fCiXt2pVptU4Wyuc-t5xj2GUprDnNKySC1D3w6DfEZ9UGjtIHSj20MLMF_kzVJjkUDGKSFJjshJrydYqek3dxql2lVirVIMITiDlDkiH3bN-CUi3ypXb7BPJkcSMQsRebNVwN0vdXocEdlTzd4_91vApAKHeGtC7_77y2PyLMXSwygBuzohB81q495DfNaUA7DKqRyQJ2cX1zc_B6HKAc8JywfBUv8CqW5Dzw
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgSMALgg1GYICREEhI0ZrEl4QXVBBTYe2eNmlvluPLqLQlpU2F9pP4l5zjOt0iJF5r13J07sefPxPyDglduHBF6g1eyZEZS7V0LPWVNxXzpR45LBRnJ2Jyxn6c8_PYcFtFWGXvE4Ojtq3BHvlhju6WMygvPi9-pfhqFJ6uxic07pJ7rCgYQvrk-U3BBTW6iCeZWSkOVxDbGGIuqhTyoDLlg1gUKPv_dcy3ItMQNXkrDB09Jo9i_kjHG4E_IXdcs0v2xg3UzlfX9D0NiM7QKt8l92fx4HyP_Jm2v1OLYPXuml7OF23gZ5g3FL1fIEtoL-lFCyvrrocIUGSRWFGYhJzGKYLQaaRhXVHs31IzALPSeNizorqxtG_q0iuk_OzWYaHjFnLUT1TTpeuWbX_Lk-IrvcuOBqrbp-Ts6Nvp10kaX2lIDWRLXWpcnjnNRWFsVZc-N7I2ljPPhK5k7UoBVl5rzwrHRkZLYR1S-nnmfOlFaU3xjOw0beOeE-qNtVzKWhY1CNPKmulMMw11tK0ra1lCPvbyUosNGYcKRUwp1Ea4CoSrULiKJ-QLSnQ7EXm0ww_t8kJFs1SVs6UurecF95hKaQ57yusqtwxjOyzyAfVBobWD0I2OlxZgv8ibpcYig4pTQpGckIPBTLBSMxzuNUpFL7FSNzqdkLfbYfwnIt8a165xTiFHEjELCdnfKOD2k8B95mBpeULkQDUH3zwcaeY_A4e4qCB15tWL_2_rDXkwOZ1N1fT7yfFL8jDHXsMoA-s5IDvdcu1eQULW1a-D1f0FG8Y5SQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMvXDYuhQFGQiAhpW0Sx054K4NqsIv2wKSJF8vXUdEmVZsKjX_Ev-QcN6kaeNtrfWLZ6udzsT9_JuQNCrpk3KWRN3glR8QsUsKxyBfeFMznauiwUDw940cX7Otldrn11Fcg7Rs96ZfTWb-c_AjcyvnMDFqe2OD89JAXEPezYjC3fnCb3IE1mxRtod7UWlCe8-YQM875YAlhjSHdooggBcojfLAGwJfAOJNORArC_f-756341OVObgWj8X3yvZ3GmoPys7-qdd_8_kfh8UbzfEDuNSkqHa1NHpJbrtwj-6MSyvPZNX1LA2k07Mbvkd3T5mx-n_w5qX5FFvnw9TWdTuZVkICYlBQdbNBjqKb0qoKeVd2yECgKVSwpGKFscoQ8d9oovS4pbhFT0-HL0uY8aUlVaWm7b0xnqCpar0JHxxWkwR-oogtXL6r2IinFh4AXNQ1quo_Ixfjzt8OjqHkIIjKQkNWRcUnsVMZTYwud-8QIbWzGPOOqENrlHByJVp6ljg2NEtw6VA30zPnc89ya9DHZKavSPSXUG2szIbRIdcoyKzRTsWIKSnWrC2tZj7xvwSDna70PGeqknMs1iCSASCKIZNYjHxEuG0OU6g4_VIsr2fyRsnA2V7n1WZp5zNZUBmNKdJFYhukDdPIOwSbRoQCijGruRcB4UZpLjngMRa2AOrxHDjqW4AhMt7mFq2wc0VImmKVkDKryHnm9acYvkVxXumqFNqkYCqRF9MiTNbo3U2oXSY-IDu47c-62AJqDTHmD3mc3_vIV2T3_NJYnX86On5O7CW50DGNYvwdkp16s3AvIBmv9Mqz7v1-SZAI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low-density+lipoprotein+cholesterol+goal+attainment+rates+in+high-risk+patients+with+cardiovascular+diseases+and+diabetes+mellitus+in+Korea%3A+a+retrospective+cohort+study&rft.jtitle=Lipids+in+health+and+disease&rft.au=Yang%2C+Ye+Seul&rft.au=Yang%2C+Bo+Ram&rft.au=Kim%2C+Mi-Sook&rft.au=Hwang%2C+Yunji&rft.date=2020-01-11&rft.pub=BioMed+Central+Ltd&rft.issn=1476-511X&rft.eissn=1476-511X&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12944-019-1158-5&rft.externalDocID=A618717409
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon